BR9710604A - Vacina de herpesv¡rus de montagem deficiente - Google Patents

Vacina de herpesv¡rus de montagem deficiente

Info

Publication number
BR9710604A
BR9710604A BR9710604A BR9710604A BR9710604A BR 9710604 A BR9710604 A BR 9710604A BR 9710604 A BR9710604 A BR 9710604A BR 9710604 A BR9710604 A BR 9710604A BR 9710604 A BR9710604 A BR 9710604A
Authority
BR
Brazil
Prior art keywords
herpesvirus
assembly
vaccine
poorly assembled
herpesvirus vaccine
Prior art date
Application number
BR9710604A
Other languages
English (en)
Inventor
Paul J Hippenmeyer
Anne M Rankin
Verne A Luckow
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of BR9710604A publication Critical patent/BR9710604A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BR9710604A 1996-07-26 1997-07-25 Vacina de herpesv¡rus de montagem deficiente BR9710604A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/687,820 US5972666A (en) 1996-07-26 1996-07-26 Assembly-deficient herpesvirus vaccine
PCT/US1997/014192 WO1998004286A2 (en) 1996-07-26 1997-07-25 Assembly-deficient herpesvirus vaccine

Publications (1)

Publication Number Publication Date
BR9710604A true BR9710604A (pt) 1999-08-17

Family

ID=24761993

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710604A BR9710604A (pt) 1996-07-26 1997-07-25 Vacina de herpesv¡rus de montagem deficiente

Country Status (14)

Country Link
US (1) US5972666A (pt)
EP (1) EP0956045B1 (pt)
JP (1) JP2000516597A (pt)
CN (1) CN1230893A (pt)
AT (1) ATE277634T1 (pt)
AU (1) AU3977997A (pt)
BR (1) BR9710604A (pt)
CA (1) CA2261071A1 (pt)
CZ (1) CZ17999A3 (pt)
DE (1) DE69730993T2 (pt)
DK (1) DK0956045T3 (pt)
ES (1) ES2231884T3 (pt)
PT (1) PT956045E (pt)
WO (1) WO1998004286A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50012015D1 (de) * 1999-02-04 2006-03-30 Joern Bullerdiek Mittel zur prävention und/oder behandlung einer gewebeveränderung mesenchymalen ursprungs
US6291226B1 (en) * 1999-02-25 2001-09-18 National Research Council Of Canada Adenovirus mutants with deleted protease gene
HUP0202738A3 (en) * 1999-09-10 2003-12-29 Akzo Nobel Nv Equine herpes virus temperature sensitive mutant and live vaccine thereof
WO2001078776A1 (en) * 2000-04-13 2001-10-25 Avant Immunotherapeutics, Inc. Herpes virus complementing cell line
AU2002305914A1 (en) * 2001-01-12 2002-10-21 Chiron Corporation Nucleic acid mucosal immunization
US7968298B2 (en) * 2001-03-28 2011-06-28 The United States Of America As Represented By The Department Of Health And Human Services Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication
WO2005021746A1 (ja) * 2003-08-29 2005-03-10 Virus Ikagaku Kenkyusho Inc. Ｈｈｖ−６またはｈｈｖ−７由来の組換ウイルスベクター、その製造方法、それを用いた宿主細胞の形質転換方法、それにより形質転換された宿主細胞およびそれを用いた遺伝子治療方法
US20080089910A1 (en) * 2004-06-29 2008-04-17 Visalli Et Al Attenuated Herpes Simplex Virus Type-2, Vectors Thereof and Immunogenic Compositions Thereof
US7628993B2 (en) 2006-07-20 2009-12-08 Vical Incorporated Compositions and methods for vaccinating against HSV-2
CN111117974B (zh) * 2019-12-20 2022-02-22 华南农业大学 一种可视化绿色荧光猪伪狂犬病毒及其构建方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102126D0 (en) * 1991-01-31 1991-03-13 Smithkline Beecham Biolog Novel vaccine
JPH05236967A (ja) * 1991-05-07 1993-09-17 Medical Res Council ヘルペスウイルス粒子及びワクチン
WO1996012007A1 (en) * 1994-10-17 1996-04-25 Merck & Co., Inc. Stable recombinant hcmv protease
US5728557A (en) * 1995-06-01 1998-03-17 Merck & Co., Inc. Method of making herpes simplex type 1 mutants and mutants so produced

Also Published As

Publication number Publication date
EP0956045A2 (en) 1999-11-17
CN1230893A (zh) 1999-10-06
EP0956045B1 (en) 2004-09-29
DE69730993T2 (de) 2005-10-06
CZ17999A3 (cs) 1999-07-14
ATE277634T1 (de) 2004-10-15
US5972666A (en) 1999-10-26
DK0956045T3 (da) 2005-01-24
WO1998004286A2 (en) 1998-02-05
CA2261071A1 (en) 1998-02-05
PT956045E (pt) 2005-01-31
ES2231884T3 (es) 2005-05-16
JP2000516597A (ja) 2000-12-12
WO1998004286A3 (en) 1998-05-14
AU3977997A (en) 1998-02-20
DE69730993D1 (de) 2004-11-04

Similar Documents

Publication Publication Date Title
BR9710604A (pt) Vacina de herpesv¡rus de montagem deficiente
PT757717E (pt) Vacinas de papilomavirus
DE69333814D1 (de) Genetischer impfstoff gegen den immunschwäche virus
DK1021547T3 (da) Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf
ATE288489T1 (de) Vp-antigene des jc-virus
DE3268361D1 (en) New vaccine and therapy against non-a non-b viral hepatitis, and their preparation process
AU6489986A (en) Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same
AU3188989A (en) Virally modified tumour vaccines for immunotherapy of tumour metastases
DE69332501D1 (en) Herpesvirus impfstoffe
SE7504221L (sv) Cellvirusvaccin och forfarande for framstellning av vaccinet.
DE69535466D1 (de) Replikationsmangelhafte mutanten von herpesvirus
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
ATE248604T1 (de) Avirulente herpetische viren verwendbar als tumorzerstörendes agens und impfstoff
NZ242641A (en) Herpesvirus particles lacking a capsid and viral dna and viral preparations containing them
WO1996001615A3 (en) Hepatitis a virus deletion mutants and vaccine formulations containing the same
DK0929315T3 (da) Krydsbeskyttende equine herpesviruspræparater, deres fremstilling og anvendelse
SE8700466D0 (sv) Vaccines against melanoma
FR2580176B1 (fr) Vaccin antirabique avirulent
DE3779444D1 (de) Impfstoff gegen herpes simplex.
CA2247177A1 (en) Methods for detecting antibodies to hav 3c proteinase
ATE46264T1 (de) Thymidinkinase-negativ-temperaturbestaendiger rinder herpes-virus-1-mutant als vakzin gegen infektioese rinder-rhinotracheitis.
NZ334582A (en) Polyprotein construct of a papillomavirus

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements